[ad_1] STOCKHOLM, Nov. 6, 2024 /PRNewswire/ — (IDS) Congress in Bruges, Belgium. The analysis will be presented at a Satellite Symposium organized by Abbott. The results support the robustness of the treatment effects and underscore […]
Trending Stories
A Game-Changer in Overcoming GLP-1-Associated Muscle Loss
[ad_1] Fat Loss Augmentation + Lean Mass Increase Hanmi Presents Three Breakthrough Findings on Novel Obesity Drugs at 2024 ObesityWeekHigh Quality Obesity Management by Targeting the CRF2 Receptor: Enhanced Fat Loss with Lean Mass IncreaseImproved […]
Volta Power Answers Hungary pursues ‘The Copper Mark’ award
[ad_1] The “Copper Mark” is the chief promise framework to advertise accountable practices around the copper business that considers the environmental, social and governance problems, from mining to processing, within the copper business. CEO Kwak Keun-man […]
ASH 2024 | Results From Three Clinical Studies of Ascentage Pharma’s Bcl-2 Inhibitor Lisaftoclax Selected for Presentations, Including an Oral Report
[ad_1] ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today […]
Invitation to presentation of BioArctic’s third quarter report for July
[ad_1] STOCKHOLM, Nov. 6, 2024 /PRNewswire/ — BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) will publish the company’s third quarter report for July – September 2024 on Thursday, November 14, 2024, at 08:00 a.m. CET. […]
